Skip to search formSkip to main contentSkip to account menu

Cisapride

Known as: cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide, (+-)-Cisapride, Cisapridum 
A substituted piperidinyl benzamide prokinetic agent. Cisapride facilitates release of acetylcholine from the myenteric plexus, resulting in… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryThe effects of the benzamide cisapride (C) (8 mg) i.v. have been compared to placebo (P) in a double blind randomised… 
2001
2001
For 2 decades Health Canada has been studying and tinkering with its prescription drug surveillance system. It's switched to cost… 
2000
2000
Background—Several cases of QT prolongation and ventricular tachyarrhythmia have been reported with domperidone, a gastrokinetic… 
1996
1996
Medical treatment of duodenogastroesophageal reflux in postgastrectomy patients has been disappointing. Using ambulatory… 
Review
1996
Review
1996
Serious cardiac arrhythmias including ventricular tachycardia, ventricular fibrillation, torsades de pointes, and Q-T… 
1995
1995
A controlled multi-centre clinical trial was conducted for evaluating the efficacy and safety of cisapride in the treatment of… 
1994
1994
Several studies have shown the relationship between gastro-oesophageal reflux, bronchial asthma and chronic nocturnal cough and… 
1993
1993
The gastrointestinal prokinetic agent cisapride has been studied by Prescription‐Event Monitoring (PEM) in 13,234 patients who… 
1986
1986
The influence of the prokinetic drug cisapride on the release of gastrointestinal hormones was studied in volunteers. First… 
1986
1986
The effect of cisapride, a new gastrokinetic drug, on gastric emptying and duodenogastric reflux of bile salts was tested in…